Avaliação farmacocinética de comprimidos contendo lamivudina e zidovudina em plasma humano

Nascimento, João Eudes do Nascimento; Magalhães, Nereide Stela Santos; Ribeiro, Roseane Maria; Pontes, Adriana; Alves, Antônio José.
RBCF, Rev. bras. ciênc. farm. (Impr.) ; 40(1): 59-66, jan.-mar. 2004. ilus, tab, graf
Artigo em Português | LILACS | ID: lil-391013

Documentos relacionados

  1. Bioequivalence and Pharmacokinetics Study of Two Zidovudine/Lamivudine Tablets in Chinese Healthy Volunteers.
  2. Assessment of complex genomic alterations induced by AZT, 3TC, and the combination AZT +3TC.
  3. Zidovudine, tenofovir or abacavir? Different adverse effect profiles.
  4. Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand.
  5. Influence of a herbal preparation on the pharmacokinetics of highly active antiretroviral therapy drugs in rats.
  6. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
  7. Triple-drug antiretroviral therapy results in lower HIV maternal-fetal transmission rates but increased adverse effects compared with zidovudine alone.
  8. Validation of a sensitive LC/MS/MS method for the determination of zidovudine and lamivudine in human plasma.
  9. Comparative Application of PLS and PCR Methods to Simultaneous Quantitative Estimation and Simultaneous Dissolution Test of Zidovudine - Lamivudine Tablets.
  10. Continuous wavelet transforms for the simultaneous quantitative analysis and dissolution testing of lamivudine-zidovudine tablets.